carglumic acid 200 MG Tablet for Oral Suspension [Carbaglu]

RxNorm concept 905394, branded drug (sbd). Prescribable name: Carbaglu 200 MG Tablet for Oral Suspension.

RxCUI: 905394
Term type: Branded drug (SBD)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/905394 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

carglumic acid 401713

Other names

Carbaglu 200 MG Dispersible Tablet for Oral Suspension

Related concepts

carglumic acid 200 MG (SCDC, consists of)
carglumic acid 200 MG [Carbaglu] (SBDC, consists of)
Tablet for Oral Suspension (DF, has dose form)
Carbaglu (BN, has ingredient)
carglumic acid 200 MG Tablet for Oral Suspension (SCD, tradename of)

Linked data

NDCs

NDC-11s RxNorm links to this concept; linked ones open their FDA product.

Use it

Look up 905394 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/905394 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 905394. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.